Suppr超能文献

局部进展期胰头癌行门静脉或肠系膜上静脉切除的胰十二指肠切除术结果

Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.

作者信息

Shimoda Mitsugi, Mori Shozo, Kita Junji, Sawada Tokihiko, Kubota Keiichi

出版信息

Hepatogastroenterology. 2013 Nov-Dec;60(128):2094-8.

Abstract

BACKGROUND/AIMS: It is known that portal vein (PV) or superior mesenteric vein (SMV) is easily invaded by locally advanced pancreatic head cancer due to anatomical characteristics. Few studies have investigated the results of PD with PV or SMV resection (PVR) for pancreatic head cancer.

METHODOLOGY

We retrospectively reviewed a database of 83 patients who had undergone PD for pancreatic head cancer (PC). We divided them into two groups, a group with PD and PVR (PD +PVR G) and a group with PD and no PVR (PD -PVR G). The clinicopathological findings and mortality were analyzed.

RESULTS

Twenty-nine of the 83 patients (34.9%) needed PD with PVR. Median survival and disease free survival were 20.4 months and 10.6 months, respectively. The 5-year overall survival rate was 8.1% in PD +PVR G and 7.4% in PD -PVR G, respectively. There was no difference between the two groups (p = 0.091, HR: 1.576; 95% CI: 0.9299-2.670). The 5-year disease free survival rate was 9.6% in PD +PVR G and 10.2% in PD -PVR G, respectively. Also, there was no difference between the two groups (p = 0.206, HR: 1.414; 95% CI: 0.8264-2.420).

CONCLUSIONS

Since PVR by itself is not a risk factor of postoperative morbidity and mortality and contributes to improving 5-year overall survival and disease free survival, PVR should be done for selected cases with locally advanced pancreas head cancer.

摘要

背景/目的:由于解剖学特征,已知门静脉(PV)或肠系膜上静脉(SMV)容易被局部进展期胰头癌侵犯。很少有研究调查胰头癌行门静脉或肠系膜上静脉切除(PVR)的胰十二指肠切除术(PD)的结果。

方法

我们回顾性分析了83例行胰头癌(PC)胰十二指肠切除术患者的数据库。我们将他们分为两组,一组行胰十二指肠切除术加门静脉或肠系膜上静脉切除(PD + PVR组),另一组行胰十二指肠切除术但未行门静脉或肠系膜上静脉切除(PD - PVR组)。分析临床病理结果和死亡率。

结果

83例患者中有29例(34.9%)需要行胰十二指肠切除术加门静脉或肠系膜上静脉切除。中位生存期和无病生存期分别为20.4个月和10.6个月。PD + PVR组的5年总生存率为8.1%,PD - PVR组为7.4%。两组之间无差异(p = 0.091,HR:1.576;95% CI:0.9299 - 2.670)。PD + PVR组的5年无病生存率为9.6%,PD - PVR组为10.2%。两组之间也无差异(p = 0.206,HR:1.414;95% CI:0.8264 - 2.420)。

结论

由于门静脉或肠系膜上静脉切除本身不是术后发病和死亡的危险因素,且有助于提高5年总生存率和无病生存率,因此对于选定的局部进展期胰头癌病例应行门静脉或肠系膜上静脉切除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验